Effect of Risk Mitigation Guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort studyAmanda Slaunwhite, Bohdan Nosyk, E. Krebs et al.|BMJ|2024Cited by 95
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment ReceiptJeong Eun Min, Bohdan Nosyk, Brenda Carolina Guerra‐Alejos et al.|JAMA Network Open|2024Cited by 14
Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: A retrospective cohort study from British Columbia, CanadaSamantha Young, Seonaid Nolan, Nadia Fairbairn et al.|Addiction|2025Cited by 1
Association Between Prescribed Stimulant Medications and Overdose Among Individuals Receiving Opioid Agonist Therapy: A Retrospective Cohort Study From British Columbia, CanadaSamantha Young, Seonaid Nolan, M. Cui et al.|Drug and Alcohol Dependence|2024Cited by 0